CRS: Whitman-Walker
Position: Pharmacist of Record
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
